Kidswell Bio Corporation

キッズウェル・バイオ

Industry: Pharmaceutical
Market: Growth
Accounting standards: Japanese GAAP
Consolidation basis: Consolidated

Notes

Consolidation basis
Consolidated / Since Mar 2025

Key metrics

Revenue(thousand JPY)

Mar 2021

996,543

Mar 2022

1,569,232

Mar 2023

2,776,241

Mar 2024

2,431,236

Mar 2025

5,082,053

Operating profit(thousand JPY)

Mar 2021

-969,687

Mar 2022

-919,118

Mar 2023

-550,929

Mar 2024

-1,335,597

Mar 2025

27,882

Operating profit margin(%)

Mar 2021

-97.31

Mar 2022

-58.57

Mar 2023

-19.84

Mar 2024

-54.93

Mar 2025

0.55

Profit before tax(thousand JPY)

Mar 2021

-999,680

Mar 2022

-533,759

Mar 2023

-656,224

Mar 2024

-1,420,527

Mar 2025

72,867

Profit(thousand JPY)

Mar 2021

-1,001,461

Mar 2022

-535,259

Mar 2023

-657,434

Mar 2024

-1,422,078

Mar 2025

-21,140

Total assets(thousand JPY)

Mar 2021

3,933,952

Mar 2022

3,503,335

Mar 2023

3,894,765

Mar 2024

5,085,550

Mar 2025

7,008,496

Cash and cash equivalents(thousand JPY)

Mar 2021

1,461,158

Mar 2022

1,187,189

Mar 2023

1,067,162

Mar 2024

2,231,411

Mar 2025

2,995,435

Cash flows from operating activities(thousand JPY)

Mar 2021

-1,267,471

Mar 2022

-1,169,561

Mar 2023

-1,421,259

Mar 2024

-453,634

Mar 2025

936,707

Cash flows from investing activities(thousand JPY)

Mar 2021

-22,290

Mar 2022

526,509

Mar 2023

-28,825

Mar 2024

Mar 2025

65,077

Cash flows from financing activities(thousand JPY)

Mar 2021

718,345

Mar 2022

369,083

Mar 2023

1,356,312

Mar 2024

1,617,883

Mar 2025

-240,061

Return on equity(-)

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Equity ratio(%)

Mar 2021

Mar 2022

43.8

Mar 2023

26.6

Mar 2024

13.2

Mar 2025

19.1

Earnings per share(JPY per share)

Mar 2021

-34.79

Mar 2022

-17.35

Mar 2023

-20.77

Mar 2024

-40.23

Mar 2025

-0.52

Net assets per share(JPY per share)

Mar 2021

50.44

Mar 2022

48.79

Mar 2023

32.36

Mar 2024

21.35

Mar 2025

30.5

Dividend per share(-)

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Payout ratio(-)

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.